Double or compound sarcomere mutations in hypertrophic cardiomyopathy: A potential link to sudden death in the absence of conventional risk factors

Heart Rhythm

Volumn 9, Issue 1, 2012, Pages 57-63

  Maron, Barry J ^a   Maron, Martin S ^b   Semsarian, Christopher ^c  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cardiomyopathy; Genetics; Hypertrophy; Sudden death

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GENE DOSAGE; GENETIC SCREENING; HEART ARREST; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MUTATION; PRIORITY JOURNAL; RISK FACTOR; SARCOMERE; SUDDEN DEATH; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; RISK ASSESSMENT; RISK FACTORS; SARCOMERES; YOUNG ADULT;

EID: 84555222948     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.08.009     Document Type: Article

References (28)

1. J.G. Seidman, C.E. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigm Cell 104 2001 557 567 (Pubitemid 32201950)
2. R. Alcalai, J.G. Seidman, C.E. Seidman Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics J Cardiovasc Electrophysiol 19 2008 104 110
3. B.J. Maron, W.J. McKenna, G.K. Danielson Task Force on Clinical Expert Consensus Documents American College of Cardiology; Committee for Practice Guidelines European Society of Cardiology American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
4. B.J. Maron Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy Circulation 121 2010 445 456
5. B.J. Maron, P. Spirito, W.-K. Shen Implantable cardioverter- defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412 (Pubitemid 47124061)
6. B.J. Maron, M.S. Maron, J.R. Lesser Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high-risk status Am J Cardiol 101 2008 544 547 (Pubitemid 351200495)
7. P.M. Elliott, J. Poloniecki, S. Dickie Sudden death in hypertrophic cardiomyopathy: identification of high-risk patients J Am Coll Cardiol 36 2000 2212 2218
8. B.J. Maron, M.S. Maron, B.A. Maron Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 57 2011 2454 2456
9. A.P. Landstrom, M.J. Ackerman Is genotype clinically useful in predicting prognosis in hypertrophic cardiomyopathy? Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy Circulation 122 2010 2441 2450
10. C.Y. Ho Is genotype clinically useful in predicting prognosis in hypertrophic cardiomyopathy Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy Circulation 122 2010 2430 2440
11. S.L. VanDriest, M.J. Ackerman, S.R. Ommen Prevalence and severity of "benign" mutations in the beta myosin heavy chain, cardiac troponin-T, and alpha tropomyosin genes in hypertrophic cardiomyopathy Circulation 106 2002 3085 3090 (Pubitemid 35440293)
12. M.J. Ackerman, S.L. VanDriest, S.R. Ommen Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T gene in hypertrophic cardiomyopathy J Am Coll Cardiol 39 2002 2042 2048 (Pubitemid 34628288)
13. C. Semsarian, B. Yu, C. Ryce, H. Washington, C. Lawrence, R. Trent Sudden cardiac death in familial hypertrophic cardiomyopathy: are benign mutations really benign? Pathology 29 1997 305 308
14. M. Kelly, C. Semsarian Multiple mutations in genetic cardiovascular disease: a marker of disease severity? Circ Cardiovasc Genet 2 2009 182 190
15. J. Ingles, A. Doolan, C. Chiu, J. Seidman, C. Seidman, C. Semsarian Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counseling J Med Genet 42 2005 e59
16. T. Tsoutsman, M. Kelly, D.C. Ng Severe heart failure and early mortality in a double mutation mouse model of familial hypertrophic cardiomyopathy Circulation 117 2008 1820 1823
17. F. Girolami, C.Y. Ho, C. Semsarian Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations J Am Coll Cardiol 55 2010 1444 1453
18. B.J. Maron Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy Circ J 74 2010 2271 2282
19. Clinical Molecular Genetics Society (CMGS) Practice guidelines for the interpretation and reporting of unclassified variants (UVs) in clinical molecular genetics http://www.cmgs.org/BPGs/pdfs%20current%20bpgs/ UV%20GUIDLINES%20ratified.pdf Accessed January 5, 2011
20. S.L. Van Driest, V.C. Vasile, S.R. Ommen Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 1903 1910 (Pubitemid 39424094)
21. J. Mogensen, R.T. Murphy, T. Kubo Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 2315 2325 (Pubitemid 39647604)
22. J. Erdmann, S. Daehmlow, S. Wischke Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy Clin Genet 64 2003 339 349 (Pubitemid 37236134)
23. H. Morita, H.L. Rehm, A. Menesses Shared genetic causes of cardiac hypertrophy in children and adults N Engl J Med 358 2008 1899 1908 (Pubitemid 351620110)
24. B.J. Maron, H. Niimura, S.A. Casey Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations J Am Coll Cardiol 38 2001 315 321 (Pubitemid 32721755)
25. P. Richard, P. Charron, L. Carrier EUROGENE Heart Failure Project Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy Circulation 107 2003 2227 2232 (Pubitemid 36547217)
26. P. Richard, R. Isnard, L. Carrier Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy J Med Genet 36 1999 542 545 (Pubitemid 29301596)
27. A. Frazier, D.P. Judge, S.P. Schulman, N. Johnson, K.W. Holmes, A.M. Murphy Familial hypertrophic cardiomyopathy associated with cardiac beta-myosin heavy chain and troponin I mutations Pediatr Cardiol 4 2008 846 850
28. H. Itoh, W. Shimizu, K. Hayashi Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study Heart Rhythm 7 2010 1411 1418